Proof & Glow.Browse

Exosome therapy

Also known as: exosomes, extracellular vesicles, EV therapy, stem cell exosomes, topical exosomes

Exosomes are nanoscale packets that cells release to carry proteins and genetic signals to other cells; aesthetic products derive them from lab-grown stem cells, platelets, plants, or milk and apply them topically after microneedling or laser, or in some clinics inject them. Marketing has sprinted far ahead of the science. Human evidence consists mostly of small, short, often unblinded studies, frequently confounded by the device treatment given alongside. No exosome product has FDA approval for any use, and the FDA has warned against injected exosomes after serious adverse events. This is the clearest case in aesthetics of hype outpacing data.

How it works

Exosomes are 30 to 150 nanometer vesicles containing growth factors, lipids, and RNA. The theory is that vesicles harvested from stem cell cultures can transfer regenerative signals to skin cells, boosting collagen synthesis, calming inflammation, and activating hair follicles. Whether commercial topical products contain functional exosomes at meaningful doses, and whether intact vesicles penetrate skin without needling, are both open questions.

What the evidence says, claim by claim

These are the results measured in studies, not the results shown in ads. Where the research is weak, the grade says so.

For wrinkles and fine lines

Limited evidence

A 2026 systematic review and meta-analysis of human clinical trials in aesthetic medicine reported average facial wrinkle reduction of 20.2 percent and improvements of 14.7 to 23.4 percent across elasticity, texture, and pigmentation endpoints, with few adverse events. The catch: included trials were small, follow-up was short, products varied wildly in source and content, and many protocols paired exosomes with microneedling or laser, which improve skin on their own. A separate 2026 systematic review reached the same conclusion: promising signals, but standardized controlled trials are still missing.

Only small, short, or lower-quality studies exist. Treat marketing claims about this use with caution.

For dullness and texture

Not enough evidence

Topical exosome serums sold for glow and texture are cosmetics, not drugs, and a 2026 scoping review of the commercial market found products varied widely in exosome source and disclosed almost nothing about isolation methods, concentration, or shelf life, with minimal clinical evidence per product. There is no way for a buyer to verify a given bottle contains active exosomes at all. Individual small studies show texture improvements after device-assisted application, but the device is a confounder.

The marketing has moved faster than the research. There is no good human data behind this use yet.

For hair thinning and loss

Not enough evidence

A 2023 systematic review of exosomes for hair restoration found 16 studies, of which 15 were preclinical (cells and animals) and only 1 was in humans: a report of 39 androgenetic alopecia patients showing increased hair density and thickness with topical adipose stem cell exosomes, without a control group. Animal biology is promising, but one uncontrolled human study is not evidence a paid treatment works. Established options like minoxidil, finasteride, and PRP all have far more human data.

The marketing has moved faster than the research. There is no good human data behind this use yet.

Risks and what can go wrong

Reported side effects in published studies are mild: redness, irritation, and transient swelling, usually attributable to the accompanying microneedling or laser. The bigger safety issue is regulatory: the FDA issued a public safety notification in December 2019 after patients in Nebraska suffered serious adverse events from unapproved injected exosome products, and reported harms from unapproved regenerative products have included infections and tumor formation. The agency has since sent multiple warning letters to exosome manufacturers. Injected or IV exosomes are unapproved biologics and legal only inside registered clinical trials. Because products are unstandardized, sterility and content cannot be assumed; anyone offered exosome injections should decline outside a formal trial.

The practical details

Clinics typically charge 600 to 2,000 dollars per session for exosome-added microneedling or post-laser application, often in series of 3. Duration of any benefit is unknown; published follow-up rarely exceeds 3 to 6 months. FDA status is unambiguous: no exosome product is FDA approved for any indication, topical cosmetics are unregulated for efficacy, and injectable use is not legal outside an Investigational New Drug trial. If paying for this, you are funding an experiment without the safeguards of one.

The Proof Sheet

One treatment, graded against the research, every week. Free. No product pushes, because we have nothing to sell you.

Email us to join the first issue